A recent Journal of Drugs in Dermatology study looked at the diversity of patients enrolled in melasma clinical trials to determine if there are any disparities in representation.
Read this interview with author Jared Jagdeo, MD, MS, associate professor of dermatology and director of the Center for Photomedicine at SUNY Downstate Medical Center. Learn Dr. Jagdeo’s key takeaways from the study and hear his advice for researchers in increasing representation in a study population.
Register for Skin of Color Update 2025 and learn the latest in the pathogenesis, diagnosis, and treatment of melasma.
